212 related articles for article (PubMed ID: 25277379)
1. Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.
Friesland A; Weng Z; Duenas M; Massa SM; Longo FM; Lu Q
Neurotoxicology; 2014 Dec; 45():81-90. PubMed ID: 25277379
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
[TBL] [Abstract][Full Text] [Related]
3. Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies.
Yang T; Tran KC; Zeng AY; Massa SM; Longo FM
Sci Rep; 2020 Nov; 10(1):20322. PubMed ID: 33230162
[TBL] [Abstract][Full Text] [Related]
4. Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.
Nguyen TV; Shen L; Vander Griend L; Quach LN; Belichenko NP; Saw N; Yang T; Shamloo M; Wyss-Coray T; Massa SM; Longo FM
J Alzheimers Dis; 2014; 42(2):459-83. PubMed ID: 24898660
[TBL] [Abstract][Full Text] [Related]
5. Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery.
Nguyen TV; Crumpacker RH; Calderon KE; Garcia FG; Zbesko JC; Frye JB; Gonzalez S; Becktel DA; Yang T; Tavera-Garcia MA; Morrison HW; Schnellmann RG; Longo FM; Doyle KP
J Pharmacol Exp Ther; 2022 Feb; 380(2):126-141. PubMed ID: 34893553
[TBL] [Abstract][Full Text] [Related]
6. Acute administration of the small-molecule p75(NTR) ligand does not prevent hippocampal neuron loss or development of spontaneous seizures after pilocarpine-induced status epilepticus.
Grabenstatter HL; Carlsen J; Raol YH; Yang T; Hund D; Cruz Del Angel Y; White AM; Gonzalez MI; Longo FM; Russek SJ; Brooks-Kayal AR
J Neurosci Res; 2014 Oct; 92(10):1307-18. PubMed ID: 24801281
[TBL] [Abstract][Full Text] [Related]
7. Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury.
Yin GN; Ock J; Limanjaya A; Minh NN; Hong SS; Yang T; Longo FM; Ryu JK; Suh JK
J Sex Med; 2021 Jan; 18(1):17-28. PubMed ID: 33243690
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.
James SE; Burden H; Burgess R; Xie Y; Yang T; Massa SM; Longo FM; Lu Q
Neurotoxicology; 2008 Jul; 29(4):605-12. PubMed ID: 18539332
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.
James SE; Dunham M; Carrion-Jones M; Murashov A; Lu Q
Neurotoxicology; 2010 Mar; 31(2):188-94. PubMed ID: 20060419
[TBL] [Abstract][Full Text] [Related]
10. A small molecule p75(NTR) ligand protects neurogenesis after traumatic brain injury.
Shi J; Longo FM; Massa SM
Stem Cells; 2013 Nov; 31(11):2561-74. PubMed ID: 23940017
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75
Simmons DA; Mills BD; Butler Iii RR; Kuan J; McHugh TLM; Akers C; Zhou J; Syriani W; Grouban M; Zeineh M; Longo FM
Neurotherapeutics; 2021 Apr; 18(2):1039-1063. PubMed ID: 33786806
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.
Yang T; Liu H; Tran KC; Leng A; Massa SM; Longo FM
Acta Neuropathol Commun; 2020 Sep; 8(1):156. PubMed ID: 32891185
[TBL] [Abstract][Full Text] [Related]
13. Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.
Meeker RB; Poulton W; Feng WH; Hudson L; Longo FM
J Neuroimmune Pharmacol; 2012 Jun; 7(2):388-400. PubMed ID: 22161560
[TBL] [Abstract][Full Text] [Related]
14. Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-31.
Fogle JE; Hudson L; Thomson A; Sherman B; Gruen M; Lacelles BD; Colby BM; Clary G; Longo F; Meeker RB
J Neurovirol; 2021 Apr; 27(2):302-324. PubMed ID: 33661457
[TBL] [Abstract][Full Text] [Related]
15. Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model.
Knowles JK; Simmons DA; Nguyen TV; Vander Griend L; Xie Y; Zhang H; Yang T; Pollak J; Chang T; Arancio O; Buckwalter MS; Wyss-Coray T; Massa SM; Longo FM
Neurobiol Aging; 2013 Aug; 34(8):2052-63. PubMed ID: 23545424
[TBL] [Abstract][Full Text] [Related]
16. Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice.
Xie Y; Seawell J; Boesch E; Allen L; Suchy A; Longo FM; Meeker RB
Exp Neurol; 2021 Jan; 335():113489. PubMed ID: 33007293
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA-NF-κB.
Zhu Y; Howard GA; Pittman K; Boykin C; Herring LE; Wilkerson EM; Verbanac K; Lu Q
Mol Cancer Res; 2019 Sep; 17(9):1910-1919. PubMed ID: 31189689
[TBL] [Abstract][Full Text] [Related]
18. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.
Simmons DA; Knowles JK; Belichenko NP; Banerjee G; Finkle C; Massa SM; Longo FM
PLoS One; 2014; 9(8):e102136. PubMed ID: 25153701
[TBL] [Abstract][Full Text] [Related]
19. A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.
Simmons DA; Belichenko NP; Ford EC; Semaan S; Monbureau M; Aiyaswamy S; Holman CM; Condon C; Shamloo M; Massa SM; Longo FM
Hum Mol Genet; 2016 Nov; 25(22):4920-4938. PubMed ID: 28171570
[TBL] [Abstract][Full Text] [Related]
20. The p75 neurotrophin receptor might mediate sepsis-induced synaptic and cognitive impairments.
Ji M; Yuan H; Yuan S; Xia J; Yang J
Behav Brain Res; 2018 Jul; 347():339-349. PubMed ID: 29604364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
